1Di Napoli P,Taecardi AA,Barsotti A.Long term cardioprotective action of trimtazidine and potential effect on the inflammatory process in patients with ischemic dilated cardiomyopathy[J].Heart,2007;91(2):161-165.
3Kantor PF,Lucien A,Kozak Pan,et al.The antianginal drug trimetazidine shifts cardic energy metabolism from fatty acid oxidation to glucose oxidation by inhibition mitochondrial long chaim 3-ketoacyl coenzyme A thiolase[J].Circ Res,2008;86(5):580-588.
3Di Napoli P,Taccardi AA,Barsotti A.Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy.Heart,2005,91(2):161-165.
4Kantor PF,Lucien A,Kozak R,et al.The antianginal drug trimetazidine shifts cardic energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long chain 3-ketoacyl coenzyme A thiolase.Circ Res,2000,86(5):580-588.
8Kasper EK, Agema WR, Hutchins GM, et al. The causes of dilated cardiomyopathy : a clinicopathologic review of 673 consecutive pa- tients [ J ]. J Am Coil Cardiol, 1994,23 (3) :586 - 590.
9Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the joint international and federation of cardiology World Health Organization task force on standardization of clinical nomenclature[J].Circulation,1979,(06):607-609.
10Feola M,Biggi A,Francini A. Placebo of trimetazidine (99m) Tc Tetrofosm in myocardial SPECT and low-dose dobutamine echocardiography in liberating myocardium[J].Archives of Medical Research,2006,(01):117-122.doi:10.1016/j.arcmed.2005.05.011.
